Combining advanced radiotherapy technologies to maximize safety and tumor control probability in stage III non-small cell lung cancer.
BACKGROUND: The goal of the current study was to investigate the tumor control probability (TCP) of advanced radiotherapy technologies for stage III non-small cell lung cancer (NSCLC) and to evaluate potential interplay effects between their applications. MATERIALS AND METHODS: Three-dimensional con...
Main Authors: | Guckenberger, M, Kavanagh, A, Partridge, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control.
by: Guckenberger, M, et al.
Published: (2011) -
Review of hypofractionated small volume radiotherapy for early-stage non-small cell lung cancer.
by: Brock, J, et al.
Published: (2008) -
Dose prescription complexity versus tumor control probability in biologically conformal radiotherapy.
by: South, C, et al.
Published: (2009) -
THE ROLE OF RADIOTHERAPY DELAY IN THE CHEMORADIATION TREATMENT FOR STAGE III INOPERABLE NON-SMALL CELL LUNG CANCER
by: E. P. Solov’eva, et al.
Published: (2016-02-01) -
Escalation and intensification of radiotherapy for stage III non-small cell lung cancer: opportunities for treatment improvement.
by: Fenwick, J, et al.
Published: (2009)